No GMOs, preservatives, soy, shellfish, peanuts or egg.
The peptides effects complement rather than compete with platelet-rich plasma (PRP) therapy, and some practitioners now use them in combination
Safety Considerations and UK Regulatory Status Retatrutide is not a licensed medicine in the UK
10.2174/1381612826666200523180301 51 PereiroX.RuzafaN.UrcolaJ
Brain-gut axis and pentadecapeptide BPC 157: theoretical and practical implications A review discussing the peptide's stability profile and the range of experimental models used to study it across the published preclinical literature
Rights and permissions Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( which permits unrestricted use, distribution and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made